Bruno Carlos Sangro Gómez-Acebo-rekin lankidetzan egindako argitalpenak (7)

2015

  1. Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection

    Molecular Therapy - Methods and Clinical Development, Vol. 2, pp. 15006

2013

  1. A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C

    Journal of Hepatology, Vol. 59, Núm. 1, pp. 81-88

2011

  1. A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma

    Functional and Integrative Genomics, Vol. 11, Núm. 3, pp. 419-429

  2. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection

    Journal of Hepatology, Vol. 54, Núm. 3, pp. 422-431

1998

  1. Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation

    Digestive Diseases and Sciences, Vol. 43, Núm. 6, pp. 1186-1189

1996

  1. Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C virus as the cause of the antiphospholipid syndrome

    Hepatology, Vol. 23, Núm. 2, pp. 199-204

1992

  1. Hepatitis B and C viral infections in patients with hepatocellular carcinoma

    Hepatology, Vol. 16, Núm. 3, pp. 637-641